Vaxil Bio Enters Into Definitive Agreement With Green Data Centers for Reverse Take Over
August 21, 2024 08:09 ET
|
Vaxil Bio Ltd.
Not for distribution to United States newswire services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. Any...
Vaxil Bio Enters Into Letter of Intent With Green Data in Respect of A Proposed Reverse Takeover
May 27, 2024 06:30 ET
|
Vaxil Bio Ltd.
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States ...
Vaxil Bio Proposed Reverse Takeover with Copper Bullet Terminated and Update of Research Activities
March 04, 2024 09:57 ET
|
Vaxil Bio Ltd.
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States ...
Vaxil Bio Enters Into Letter of Intent With Copper Bullet Mines in Respect of a Proposed Reverse Takeover
January 10, 2024 15:01 ET
|
Vaxil Bio Ltd.
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States ...
Vaxil Provides Update on Research Activities and Management Changes
August 02, 2023 17:00 ET
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. ("Vaxil" or the "Company") (TSX VENTURE:VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil’s Annual and Special Shareholders Meeting
April 24, 2023 19:50 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 24, 2023 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Update on Research Activities
March 07, 2022 07:50 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 07, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil’s Annual and Special Shareholders Meeting
February 08, 2022 17:30 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. 08, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Final Results on Its Previously Disclosed Research With Ben-Gurion University of the Negev
January 04, 2022 10:02 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Jan. 04, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Resignation of Director
December 13, 2021 16:30 ET
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, Dec. 13, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative biotech company announces that Mr. David Goren has resigned from the...